# Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

> **NCT07086443** · PHASE4 · RECRUITING · sponsor: **Sequence LifeScience, Inc.** · enrollment: 350 (estimated)

## Conditions studied

- Diabetic Foot Ulcer
- DFU
- Diabetic Foot Ulcer (DFU)
- Foot Ulcer Due to Type 1 Diabetes Mellitus
- Foot Ulcer Due to Type 2 Diabetes Mellitus
- Ulcer
- Ulcer Foot

## Interventions

- **OTHER:** Activate™ Matrix
- **OTHER:** AmnioDefend™ FT Matrix
- **OTHER:** Palisade™ DM Matrix
- **OTHER:** Enclose™ TL Matrix
- **OTHER:** Sentry™ SL Matrix
- **OTHER:** Shelter™ DM Matrix + SOC

## Key facts

- **NCT ID:** NCT07086443
- **Lead sponsor:** Sequence LifeScience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-11
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07086443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07086443, "Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT07086443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*